Loading clinical trials...
Loading clinical trials...
Open label prospective, non-randomised proof of principle study assessing the use of methylene blue fluorescence cholangiography.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Oxford
Collaborators
NCT07130864 · Laparoscopic Cholecystectomy, Choledocholithiasis, and more
NCT05169073 · Virtual Reality, Gallbladder, and more
NCT05709548 · Acute Cholecystitis, Bile Duct Injury
NCT05556668 · Biliary Stricture, Biliary Tract Diseases, and more
NCT05479227 · Bile Duct Injury
Oxford University Hospitals NHS Foundation Trust
Oxford
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions